The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
1 marketed package NDCs · 1 active manufacturer
Most dispensed: 3 g; .375 g · Injection, Powder, Lyophilized, For Solution · #10 vials/box / 1 injection, powder, lyophilized, for solution in 1 vial · 3 g/15mL; .375 g/15mL · Injection, Powder, For Solution · #10 vial, single-doses/carton / 15 ml in 1 vial, single-dose · 3 g/15mL; .375 g/15mL · Injection, Powder, Lyophilized, For Solution · #10 vial, single-doses/carton / 15 ml in 1 vial, single-dose · 36 g/180mL; 4.5 g/180mL · Injection, Powder, For Solution · #1 bottle/carton / 180 ml in 1 bottle
Only one company currently supplies this market — there is no backup if it stumbles.
Other molecules FDA puts in beta Lactamase Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.